Export 144 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is E  [Clear All Filters]
2018
Shinde, A. B., Baboota, R. K., Denis, S., Loizides-Mangold, U., et al. (2018). Mitochondrial disruption in peroxisome deficient cells is hepatocyte selective but is not mediated by common hepatic peroxisomal metabolites. Mitochondrion, 39, 51 - 59.
2017
Cappagli, V., Potes, C. S., Ferreira, L. B., Tavares, C., et al. (2017). Calcitonin receptor expression in medullary thyroid carcinoma. PeerJ, 2017(9).
Cappagli, V., Potes, C. S., Ferreira, L. B., Tavares, C., et al. (2017). Calcitonin receptor expression in medullary thyroid carcinoma. PeerJ, 2017(9).
Sant'Anna, R., Almeida, M. R., Varejao, N., Gallego, P., et al. (2017). Cavity filling mutations at the thyroxine-binding site dramatically increase transthyretin stability and prevent its aggregation. Scientific Reports, 7.
Domingues, N., Estronca, L. M. B. B., Silva, J., Encarnação, M. R., et al. (2017). Cholesteryl hemiesters alter lysosome structure and function and induce proinflammatory cytokine production in macrophages. Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, 1862(2), 210 - 220.
Domingues, N., Estronca, L. M. B. B., Silva, J., Encarnação, M. R., et al. (2017). Cholesteryl hemiesters alter lysosome structure and function and induce proinflammatory cytokine production in macrophages. Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, 1862(2), 210 - 220.
Piovesan, D., Tabaro, F., Mičetić, I., Necci, M., et al. (2017). DisProt 7.0: A major update of the database of disordered proteins. Nucleic Acids Research, 45(D1), D219 - D227.
Socodato, R., Santiago, F. N., Portugal, C. C., Domith, I., et al. (2017). Dopamine promotes NMDA receptor hypofunction in the retina through D1 receptor-mediated Csk activation, Src inhibition and decrease of GluN2B phosphorylation. Scientific Reports, 7.
Franquinho, F., Nogueira-Rodrigues, J., Duarte, J. M., Esteves, S. S., et al. (2017). The Dyslexia-susceptibility Protein KIAA0319 Inhibits Axon Growth Through Smad2 Signaling. Cerebral cortex (New York, N.Y. : 1991), 27(3), 1732 - 1747.
Kennelly, M., Dmochowski, R., Schulte-Baukloh, H., Ethans, K., et al. (2017). Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study. Neurourology and Urodynamics, 36(2), 368 - 375.
Kennelly, M., Dmochowski, R., Schulte-Baukloh, H., Ethans, K., et al. (2017). Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study. Neurourology and Urodynamics, 36(2), 368 - 375.
Kennelly, M., Dmochowski, R., Schulte-Baukloh, H., Ethans, K., et al. (2017). Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study. Neurourology and Urodynamics, 36(2), 368 - 375.
Afshin, A., Forouzanfar, M. H., Reitsma, M. B., Sur, P., et al. (2017). Health effects of overweight and obesity in 195 countries over 25 years. New England Journal of Medicine, 377(1), 13 - 27.
Afshin, A., Forouzanfar, M. H., Reitsma, M. B., Sur, P., et al. (2017). Health effects of overweight and obesity in 195 countries over 25 years. New England Journal of Medicine, 377(1), 13 - 27.
Afshin, A., Forouzanfar, M. H., Reitsma, M. B., Sur, P., et al. (2017). Health effects of overweight and obesity in 195 countries over 25 years. New England Journal of Medicine, 377(1), 13 - 27.
Barber, R. M., Fullman, N., Sorensen, R. J. D., Bollyky, T., et al. (2017). Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015. The Lancet, 390(10091), 231 - 266.
Barber, R. M., Fullman, N., Sorensen, R. J. D., Bollyky, T., et al. (2017). Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015. The Lancet, 390(10091), 231 - 266.
Barber, R. M., Fullman, N., Sorensen, R. J. D., Bollyky, T., et al. (2017). Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015. The Lancet, 390(10091), 231 - 266.
Barber, R. M., Fullman, N., Sorensen, R. J. D., Bollyky, T., et al. (2017). Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015. The Lancet, 390(10091), 231 - 266.
Barber, R. M., Fullman, N., Sorensen, R. J. D., Bollyky, T., et al. (2017). Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015. The Lancet, 390(10091), 231 - 266.
Barber, R. M., Fullman, N., Sorensen, R. J. D., Bollyky, T., et al. (2017). Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015. The Lancet, 390(10091), 231 - 266.
Barber, R. M., Fullman, N., Sorensen, R. J. D., Bollyky, T., et al. (2017). Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015. The Lancet, 390(10091), 231 - 266.
Barber, R. M., Fullman, N., Sorensen, R. J. D., Bollyky, T., et al. (2017). Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015. The Lancet, 390(10091), 231 - 266.
Borsari, C., Santarém, N., Torrado, J., Olías, A. I., et al. (2017). Methoxylated 2'-hydroxychalcones as antiparasitic hit compounds. European Journal of Medicinal Chemistry, 126, 1129 - 1135.
Cereija, T. B., Alarico, S., Empadinhas, N., & Pereira, P. J. B. (2017). Production, crystallization and structure determination of a mycobacterial glucosylglycerate hydrolase. Acta Crystallographica Section:F Structural Biology Communications, 73(9), 536 - 540.

Pages


Home | Site Map | Contacts | Credits | Privacy & Cookies | WHISTLEBLOWER CHANNEL | Intranet | Social Networks |


rua alfredo allen, 208, 4200-135 porto - portugal | tel +351 226 074 900 | email: info@i3s.up.pt | © copyright 2010 ibmc